<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Fish consumption and marine omega-3 fatty acid supplementation in pregnancy</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Fish consumption and marine omega-3 fatty acid supplementation in pregnancy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Fish consumption and marine omega-3 fatty acid supplementation in pregnancy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Emily Oken, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vincenzo Berghella, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Vanessa A Barss, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 12, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Maternal consumption of fish and marine omega-3 fatty acid supplements, such as <a class="drug drug_general" data-topicid="10255" href="/z/d/drug information/10255.html" rel="external">omega-3-acid ethyl esters</a> (fish oil), is an active area of investigation because of potential favorable effects on pregnancy and offspring outcome. This topic will discuss these potential benefits as well as the risks of maternal fish and fish oil consumption during pregnancy. </p><p>Issues related to the health effects of fish and these supplements in the general population are reviewed separately (see  <a class="medical medical_review" href="/z/d/html/5365.html" rel="external">"Fish oil: Physiologic effects and administration"</a>). Omega-3 fatty acid supplementation for breast- and formula-fed infants is also reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/83231.html" rel="external">"Long-chain polyunsaturated fatty acids (LCPUFA) for preterm and term infants"</a>.)</p><p class="headingAnchor" id="H2351134025"><span class="h1">BACKGROUND</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – The two major categories of polyunsaturated fatty acids (PUFAs) are the omega-3 (also called n-3) and omega-6 (also called n-6) fatty acids, based on the location of the first double bond in the fatty acid chain. The three major dietary omega-3s are eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA). EPA and DHA are omega-3 long-chain PUFAs (LCPUFAs) present in fish, shellfish, and (in much lower amounts) some other animal foods. They are the major components of fish oil supplements. ALA is an intermediate-chain omega-3 PUFA present in certain plants and their oils, such as flaxseed and walnuts. When referring to EPA and DHA, common terms include "long-chain omega-3 fatty acids," "seafood-derived omega-3 fatty acids," and "marine omega-3 fatty acids." In this topic, all omega-3 fatty acids are assumed to be long-chain unless otherwise specified.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Biology and biologic effects</strong> – Marine omega-3 fatty acids have a variety of biologic effects, including specific effects related to pregnancy. DHA and EPA are important because they are components of the phospholipids that form the structures of cell membranes (especially retina and brain). In addition, high concentrations of EPA and DHA tip the eicosanoid balance toward less inflammatory activity. Although the body can convert ALA to the more biologically active DHA and EPA, the conversion rate is very low (&lt;1 percent for DHA, &lt;10 percent for EPA). Therefore, consumption of marine omega-3 fatty acids is the most efficient means for individuals to increase their DHA and EPA levels.</p><p></p><p class="bulletIndent1">The fetus depends on transplacental transfer of DHA for optimal visual and cognitive development [<a href="#rid1">1-4</a>]. EPA appears to facilitate transfer and uptake of DHA in fetal cells [<a href="#rid5">5,6</a>]. DHA is preferentially incorporated into the rapidly developing fetal brain during the last trimester of pregnancy, concentrating in the gray matter and retinal membranes [<a href="#rid1">1,4</a>]. Autopsy analysis estimates that the fetus accumulates 50 to 60 mg/day of DHA during the third trimester [<a href="#rid7">7</a>]. Rapid accumulation of DHA into the central nervous system continues during the first 24 months of life, with ongoing accrual throughout childhood.</p><p></p><p class="bulletIndent1">Marine omega-3 fatty acids may have other maternal and fetal benefits. Because of the role DHA and EPA play in anti-inflammatory eicosanoid/docosanoid synthesis, signaling events, gene expression, and cytokine expression, it has been hypothesized that ensuring appropriate maternal marine omega-3 fatty acid intake during pregnancy might reduce inflammation-mediated disorders, such as preterm birth, preeclampsia, and allergic/atopic disease in offspring. (See <a class="local">'Possible reduction in preterm birth, especially among those with low baseline omega-3 LCPUFA status'</a> below and <a class="local">'Possible reduction in allergy and atopic disease'</a> below and <a class="local">'No reduction in preeclampsia'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fish as a source of DHA and EPA</strong> – Fish, including finfish and shellfish, is a healthful food that is low in saturated fat; high in protein and micronutrients, including vitamin D and iodine; and the primary dietary source of DHA and EPA. Early observational studies linked fish intake during pregnancy with gestational age at birth and neurodevelopment in offspring. Based on these data (discussed below), expert groups consistently recommend that pregnant people consume two to three servings of fish weekly. Because fish consumption also exposes the fetus to methylmercury and other environmental contaminants in fish, guidelines for fish consumption in pregnancy emphasize choosing fish species high in DHA and low in mercury. (See <a class="local">'Fish consumption'</a> below.)</p><p></p><p class="bulletIndent1">It is well-established that many pregnant individuals do not consume fish at the level required to achieve the DHA intake recommended by expert groups. For this reason, maternal consumption of marine omega-3 fatty acid supplements (eg, fish oil or derived from algae) or marine omega-3 fatty acid-fortified foods has been proposed. Although these products are alternative sources of DHA and EPA for individuals who cannot or choose not to consume fish, they may not have identical effects. This is an active area of investigation. (See <a class="local">'Marine omega-3 fatty acid supplements and fortified foods'</a> below.)</p><p></p><p class="headingAnchor" id="H2107457786"><span class="h1">POTENTIAL BENEFITS</span></p><p class="headingAnchor" id="H3675590729"><span class="h2">Possible beneficial effect on neurodevelopment</span><span class="headingEndMark"> — </span>In most prospective cohort and retrospective studies, higher maternal fish consumption during pregnancy was associated with modest improvements in neurodevelopment of offspring [<a href="#rid8">8-18</a>]. However, a 2018 Cochrane meta-analysis of randomized trials comparing marine omega-3 fatty acid intervention (food, supplements) with placebo or no marine omega-3 fatty acid intervention during pregnancy found insignificant differences between groups for childhood development (cognition, attention, behavior, vision, language, hearing, motor) [<a href="#rid19">19</a>]. In a 2022 comprehensive systematic review of the literature on fish consumption and health, the Norwegian Scientific Committee for Food and Environment (VKM) graded the evidence for a protective association between maternal total fish consumption and child neurodevelopment as "limited, suggestive" [<a href="#rid20">20</a>].</p><p>The findings from the observational studies are not necessarily discordant with those from the meta-analysis because only three trials in the meta-analysis involved fish intake rather than marine omega-3 fatty acid supplements and these trials did not evaluate neurodevelopmental outcomes. Furthermore, the supplement trials, which did evaluate this outcome, had very low or low quality evidence, so the possibility of a benefit cannot be confidently excluded. Additionally, fish consumption habits are likely to be consistent before and during pregnancy, whereas supplement trials have typically initiated treatment during the second or third trimester of pregnancy and thus cannot evaluate effects of preconception or first-trimester exposure.</p><p>However, observational studies reporting the benefits of fish consumption are limited by multiple factors. For example, prospective studies have relatively high rates of drop-out and loss to follow-up while retrospective studies have difficulties in accurately measuring the type and quantity of fish consumed. Confounding is a key issue as seafood intake may be a marker of a healthy lifestyle or socioeconomic resources [<a href="#rid21">21</a>]. Fish consumption may replace consumption of foods that are harmful, or fish may have nutrients other than marine omega-3 fatty acids that account for the observed benefits. Thus, it is possible that high prenatal fish consumption is only an indirect marker of other factors associated with a good offspring neurodevelopmental outcome. </p><p class="headingAnchor" id="H4113214967"><span class="h2">Possible reduction in allergy and atopic disease</span><span class="headingEndMark"> — </span>Supplementation with marine omega-3 fatty acids started during pregnancy has at most a weak association with reduction in allergic outcomes. In a 2019 meta-analysis of randomized trials (10 trials, over 3600 children), pooled estimates showed a reduction in childhood sensitization to egg (RR 0.54, 95% CI 0.32-0.90) and sensitization to peanut (RR 0.62, 95% CI 0.40-0.96), but no statistical differences for other allergic outcomes (eg, eczema, asthma/wheeze) [<a href="#rid22">22</a>]. The findings are inconclusive due to heterogeneity in individuals (eg, prenatal versus both prenatal and postnatal), duration and dose of supplementation, reported outcomes, and duration of follow-up (1 to 24 years); moderate to high risk of bias overall; and high loss to follow-up in half of the trials.</p><p>One of the larger trials included in the meta-analysis was a double-blind placebo-controlled randomized trial of third-trimester supplementation with high-dose (2.4 g/day) marine omega-3 fatty acids (fish oil) [<a href="#rid23">23</a>]. In this trial, the intervention resulted in a 7 percent absolute reduction in the risk of persistent wheeze or asthma in offspring followed to ages three to five years (16.9 versus 23.7 percent, hazard ratio [HR] 0.69, 95% CI 0.49-0.97), as well as a reduction in lower respiratory tract infections, but <strong>no</strong> difference in rates of asthma exacerbations, eczema, or allergic sensitization between groups. The reduction in wheeze/asthma was driven by the impact of treatment of individuals with EPA and DHA blood levels in the lowest third at baseline or with a <em>FADS</em> genotype associated with low EPA and DHA blood levels (low baseline EPA and DHA: persistent wheeze or asthma in offspring 17.5 versus 34.1 percent, HR 0.46, 95% CI 0.25-0.83). The estimated combined EPA and DHA intake of these individuals was below 321 mg/day before the intervention. Although including the specific subset of individuals with lower EPA/DHA levels in this study in the meta-analysis only modestly changed the overall estimate for asthma (from RR 0.87, 95% CI 0.70-1.07 to RR 0.83, 95% CI 0.64-1.08), other studies did not specifically stratify by low baseline fatty acid status. </p><p>Subsequent trials should address whether similar effects will be observed in other populations, whether the beneficial effects persist, and whether lower marine omega-3 fatty acid doses are effective. It would be essentially impossible to achieve a comparable marine omega-3 fatty acid dose from fish consumption since the dose was 20-fold higher than the average intake from fish consumption in the United States, and, as an example, 10 3.5 oz (100 gram) portions of Atlantic salmon would need to be consumed each day.</p><p>The effect of fish consumption on allergy outcomes has also been studied. In a meta-analysis of 31 observational studies, increased maternal fish intake was associated a lower risk of wheeze, eczema and food allergy in offspring, but no significant association with risk of asthma, allergic rhinitis, and inhalant allergy [<a href="#rid24">24</a>]. These data are subject to the usual limitations of observational studies. </p><p class="headingAnchor" id="H770131339"><span class="h2">Possible reduction in preterm birth, especially among those with low baseline omega-3 LCPUFA status</span><span class="headingEndMark"> — </span>Marine omega-3 fatty acids appear to reduce the risk for preterm birth and lengthen gestation, especially among those with low baseline omega-3 long-chain polyunsaturated fatty acid (LCPUFA) status. </p><p class="bulletIndent1"><span class="glyph">●</span>In a 2021 meta-analysis of randomized trials of omega-3 supplementation during pregnancy and risk of preterm birth, compared with placebo or no omega-3 fatty acid intervention, supplementation during pregnancy resulted in the following [<a href="#rid25">25</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reduction in preterm birth &lt;37 weeks (8.1 versus 10.1 percent; RR 0.89; 95% CI 0.82-0.97; 31 trials, over 21,000 patients)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Reduction in preterm birth &lt;34 weeks (2.4 versus 3.3 percent; RR 0.73, 95% CI 0.58-0.92; 11 trials, over 10,000 patients)</p><p></p><p class="bulletIndent1">However, asymmetry in the funnel plot's visual evaluation for this outcome suggests the absence of some trials with negative results. In addition, sensitivity analyses to explore the effects of trial quality on outcome eliminated about half of the trials and found no significant differences in preterm birth risk between the supplemented and control groups (preterm birth &lt;37 weeks: RR 0.92, 95% CI 0.83- 1.01; preterm birth &lt;34 weeks: RR 0.82, 95% CI 0.61-1.09), suggesting inclusion of low-quality trials accounted for the initially favorable results. Furthermore, the analysis did not consider the type of omega-3 supplementation, dose, timing, and length of supplementation, which are variables that might have affected the results.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In 2021, a group from the International Society for the Study of Fatty Acids and Lipids synthesized available evidence on omega-3 fatty acids during pregnancy to reduce preterm birth<strong> </strong>and came to the following conclusions [<a href="#rid26">26</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Treatment with omega-3 LCPUFA was associated with a 35 percent reduction in early preterm birth &lt;34 weeks (RR 0.65; 95% CI 0.46-0.92) and a 12 percent reduction in preterm birth &lt;37 weeks (RR 0.88; 95% CI 0.81-0.95) compared with no or minimal omega-3 fatty acid supplementation</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Mean gestational length was modestly greater in those who received omega-3 LCPUFA (mean difference 1.36 days, 95% CI 0.77-1.96)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Omega-3 LCPUFA possibly increased the incidence of pregnancies continuing beyond 42 weeks (RR 1.31; 95% CI 1.01-1.70), although the incidence was low in the more recent trials due to changes in obstetric practice that limit prolongation of pregnancy beyond the middle of the 41<sup>st</sup> week of gestation.</p><p></p><p class="bulletIndent1">Trial selection likely explains the difference in findings between this analysis [<a href="#rid26">26</a>] and the aforementioned 2021 meta-analysis [<a href="#rid25">25</a>]. In addition, individual trials have suggested that the background omega-3 LCPUFA intake or status may predict the response to supplementation, and more individuals in the general population are now taking low-dose DHA supplements than in the past.</p><p></p><p>The effect of fish consumption on preterm birth has also been studied. In a meta-analysis of 21 observational studies with a total of nearly 600,000 participants, a 45 g/day increment in seafood consumption was associated with a reduced risk of low birth weight (OR 0.65, 95% CI 0.47-0.90) and small for gestational age newborns (OR 0.84, 95% CI 0.71-0.98), and a nonlinear dose-response relationship between maternal seafood consumption and risk of preterm birth was observed, with no further benefit with intake above 45 g/day [<a href="#rid27">27</a>]. These data are subject to the usual limitations of observational studies. In a 2022 comprehensive systematic review of the literature on fish consumption and health, the Norwegian Scientific Committee for Food and Environment (VKM) graded the evidence for a protective association between maternal total fish consumption and preterm birth as "probable" [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H2462987652"><span class="h1">UNPROVEN BENEFITS</span></p><p class="headingAnchor" id="H3521105245"><span class="h2">No reduction in preeclampsia</span><span class="headingEndMark"> — </span>In the 2021 meta-analysis of randomized trials of omega-3 supplementation during pregnancy discussed above, compared with placebo or no omega-3 fatty acid intervention, supplementation had no effect on risk of preeclampsia or pregnancy-induced hypertension (6.9 versus 7.0 percent; RR 1.00, 95% CI 0.87-1.16; 19 trials, over 11,000 patients) [<a href="#rid25">25</a>]. No asymmetry was observed in the funnel plot's visual evaluation for this outcome, suggesting a low risk of bias. These findings are consistent with an earlier review [<a href="#rid28">28</a>] in which only three trials of marine omega-3 fatty acid supplementation in individuals with singleton gestations at high risk of preeclampsia or growth restriction were considered well-designed, and none reported a reduction in these outcomes [<a href="#rid29">29-31</a>].</p><p class="headingAnchor" id="H340825666"><span class="h2">No reduction in fetal growth restriction or fetal or neonatal death</span><span class="headingEndMark"> — </span>In the 2021 meta-analysis of randomized trials of omega-3 supplementation during pregnancy discussed above, compared with placebo or no omega-3 fatty acid intervention, supplementation had no significant effect on risks of [<a href="#rid25">25</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Fetal growth restriction (11.4 versus 11.0 percent; RR 1.04, 95% CI 0.92-1.18; 9 trials, over 10,000 patients)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fetal death (0.77 versus 0.69 percent; RR 1.20, 95% CI 0.85-1.69; 17 trials, over 17,000 patients)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neonatal death (0.34 versus 0.48 percent; RR 0.81, 95% CI 0.50-1.34; 10 trials, over 16,000 patients)</p><p></p><p class="headingAnchor" id="H2948030718"><span class="h1">POTENTIAL HARMS</span></p><p class="headingAnchor" id="H309996889"><span class="h2">Methylmercury in fish</span><span class="headingEndMark"> — </span>Fish consumption is the primary source of nonoccupational maternal methylmercury exposure. Some mercury exposure is inevitable if fish are consumed since it is present in all fish tissues, cannot be cooked out of the fish, and over 95 percent is absorbed from the gastrointestinal tract. This risk has resulted in reluctance of many pregnant people to eat fish [<a href="#rid32">32</a>].</p><p>The fetal brain is considered the tissue most sensitive to the harms of mercury. Exposure to methylmercury in fetal life can cause diffuse and widespread neurologic damage [<a href="#rid33">33</a>], best illustrated by episodes of community-wide mercury poisoning in Japan (Minamata disease) and Iraq [<a href="#rid34">34,35</a>]. Pregnant people exposed to high levels of methylmercury in these communities did not necessarily develop symptoms themselves, but many of their children had delayed attainment of developmental milestones and, in some cases, severe neurologic disabilities, including blindness, deafness, and cerebral palsy. (See  <a class="medical medical_review" href="/z/d/html/7179.html" rel="external">"Mercury toxicity"</a> and  <a class="medical medical_review" href="/z/d/html/5447.html" rel="external">"Overview of occupational and environmental risks to reproduction in females"</a>.)</p><p>Chronic, low-level maternal mercury exposure from habitual fish consumption may also have toxic fetal effects, prompting recommendations to limit fish consumption in pregnancy. However, the relationship between maternal fish intake and toxic fetal effects from mercury is not well-established. Concerns are based, in part, on longitudinal prospective cohort studies in New Zealand and the Faroe Islands that reported that higher prenatal methylmercury exposure from high seafood consumption was associated with decrements in attention, language, verbal memory, motor speed, and visuospatial function in offspring [<a href="#rid36">36-38</a>]. However, a similar cohort study in the Seychelles Islands (Seychelles Child Development Study) found no harmful effect of prenatal methylmercury exposure through age 19 years [<a href="#rid39">39-41</a>]. Subsequent publications from cohorts with lower mercury exposures have not shown harmful associations of prenatal mercury exposure with infant development [<a href="#rid42">42-44</a>], cognition at 6 to 10 years [<a href="#rid45">45</a>], or behavior through 11 years [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H216796191"><span class="h3">Safe level of mercury intake</span><span class="headingEndMark"> — </span>The United States Environmental Protection Agency's reference dose of methylmercury is 0.10 mcg/kg body weight/day [<a href="#rid47">47</a>]. The reference dose is an estimate (with uncertainty spanning approximately an order of magnitude) of a daily exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime.</p><p>Other regulatory agencies have made different recommendations regarding intake limits for methylmercury, and these limits are two- to threefold higher than that of the Environmental Protection Agency. The United States Agency for Toxic Substances and Disease Registry derived a Minimal Risk Level of 0.30 mcg methylmercury/kg body weight/day [<a href="#rid48">48</a>], the World Health Organization's Joint Expert Committee on Food Additives and Contaminants derived a Provisional Tolerable Intake of 0.23 mcg/kg/day [<a href="#rid49">49</a>], and the Canadian Bureau of Chemical Safety recommended a Provisional Tolerable Intake of 0.20 mcg/kg/day [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H3121709399"><span class="h3">Mercury content by type of fish</span><span class="headingEndMark"> — </span>Reference levels for mercury in commercial fish and shellfish are available <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Ffood%2Fmetals-and-your-food%2Fmercury-levels-commercial-fish-and-shellfish-1990-2012&amp;token=IF2fUU3GLn2TBX5oCwJicHdnbvMmguMENAUN%2FQLHerJeqv%2FYFwWZEsDHDoTfTbHKOaJZLL%2BQezEA2eD6h1VUQcXLR47EB3cb%2FnZnJt%2BslKHzm1KeI19bmfpesttn4B94&amp;TOPIC_ID=431" target="_blank">online</a> from data collected 1990 to 2012 by the US Food and Drug Administration, although estimates may be based on as few as three fish samples. More comprehensive information on mercury levels in commercial fish in the United States is available in a database generated in 2012 by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.stonybrook.edu%2Fcommcms%2Fgelfond%2Fmercury_and_fish%2Fdatabase&amp;token=iJ5o1HNts8I2M83pDmmTiJy%2Bl8BXjBf3fkhBpS3ojT6JoOIUF5%2B%2BtRKN%2FfiFdRHHfhNISNblnmdgOCD5aWoXP8oCwOZo3w2EFng1lyxWvMg%3D&amp;TOPIC_ID=431" target="_blank">Stony Brook University</a>, based on a much larger foundation of data aggregated from government monitoring programs and the scientific literature [<a href="#rid51">51</a>].</p><p>A limitation of all of these estimates is the variability in the mercury content of fish of the same species. For example, the mean concentration of mercury in canned light tuna is 0.128 ppm (mcg/g), with a range from 0 to 0.889 ppm. Thus, a 60 kg individual consuming 4 oz of canned light tuna per week would on average get 0.03 mcg mercury/kg body weight/week (30 percent of the reference dose) but could get none (0 percent of the reference dose) or could get as much as 0.25 mcg/kg/week (250 percent of the reference dose).</p><p class="headingAnchor" id="H572241545"><span class="h3">Screening for mercury toxicity</span><span class="headingEndMark"> — </span>Routine screening for mercury toxicity in the general population, including people planning pregnancy or currently pregnant, is <strong>not</strong> recommended.</p><p>Testing is reasonable if the individual is at risk because of suggestive neurologic symptoms and frequent consumption of fish likely to have higher mercury contamination. The most useful biomarker of methylmercury exposure in clinical practice is the level in whole blood, measured in a reliable laboratory [<a href="#rid52">52</a>]. Individuals who are found to have elevated mercury levels should be advised to avoid intake of mercury-containing fish. In a case series of high consumers of fish, mercury levels declined rapidly in the first three weeks after advice to reduce fish intake [<a href="#rid53">53</a>]. (See  <a class="medical medical_review" href="/z/d/html/7179.html" rel="external">"Mercury toxicity"</a>.)</p><p>The reference level of methylmercury in blood, set by the US Environmental Protection Agency, is 5.8 mcg/L, which is thought to define the average long-term level of mercury in blood that is without appreciable risk. However, some research suggests a level of 3.5 mcg/L would be a better threshold. In the US National Health and Nutrition Examination Survey (NHANES) 1999 to 2010, 10.8 percent of females of childbearing age in the Northeast had mercury concentrations ≥3.5 mcg/L, and 3.3 percent had concentrations ≥5.8 mcg/L [<a href="#rid54">54</a>]. Southern females were much less likely to have elevated mercury levels, and elevated levels were rare among females living in the West. High blood mercury levels were associated with greater frequency of seafood consumption and living in coastal regions.</p><p class="headingAnchor" id="H2134978811"><span class="h2">Fish oil supplements</span><span class="headingEndMark"> — </span>Harmful effects have not been reported from <a class="drug drug_general" data-topicid="10255" href="/z/d/drug information/10255.html" rel="external">omega-3-acid ethyl esters</a> (fish oil) supplementation during pregnancy. Bleeding diathesis is the most serious potential complication from high doses, but excessive bleeding after delivery has not been observed [<a href="#rid19">19</a>]. General safety issues (eg, bleeding, contaminants, cancer) are discussed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/5365.html" rel="external">"Fish oil: Physiologic effects and administration", section on 'Safety'</a>.)</p><p>Fish oil supplements contain no or minimal mercury because fish oil is generally derived from small pelagic fish used for fish feed or from formulations produced by algae [<a href="#rid55">55,56</a>]. Furthermore, most fish oil supplements have been purified to reduce environmental toxins to negligible amounts [<a href="#rid55">55</a>].</p><p>However, supplements can cause bothersome side effects. The most common are gastrointestinal disturbances such as nausea, which occurred in approximately 4 percent of individuals at doses below 3 grams/day and in approximately 20 percent of individuals at doses of ≥4 grams/day in a pooled analysis [<a href="#rid57">57</a>]. Fish oil supplements may also cause a "fishy taste" following eructation (burping), bad breath, heartburn, and odoriferous sweat [<a href="#rid58">58</a>].</p><p>In addition, the quality of fish oil supplements varies, and they are not well-monitored by regulatory agencies to ensure the product contains the amounts of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) stated on the label [<a href="#rid59">59,60</a>].</p><p class="headingAnchor" id="H82571245"><span class="h1">RECOMMENDATIONS FOR PEOPLE WHO ARE PREGNANT, PLANNING PREGNANCY, AND BREASTFEEDING</span><span class="headingEndMark"> — </span>The benefits of consumption of fish, fish oil, and marine omega-3 fatty acid-fortified foods during pregnancy remain controversial. However, randomized trials have established that encouraging pregnant people to increase fish consumption or consume marine omega-3 fatty acid supplements or fortified foods increases both maternal and fetal docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) levels [<a href="#rid61">61-63</a>].</p><p class="headingAnchor" id="H1439560010"><span class="h2">Fish consumption</span><span class="headingEndMark"> — </span>For people who may become pregnant, are currently pregnant, or are breastfeeding, expert panels worldwide suggest a minimum DHA intake of 200 to 300 mg/day [<a href="#rid64">64-68</a>]. The Food and Nutrition Board of the Institute of Medicine (IOM; now called the National Academy of Medicine) considers 1.4 grams the adequate intake for alpha-linolenic acid (ALA) in pregnancy and 1.1 grams the adequate intake for females of reproductive age; they did not establish specific intake recommendations for EPA or DHA [<a href="#rid69">69</a>].</p><p>Two to three weekly servings of fish high in DHA and low in mercury is the optimal method for obtaining DHA because no other food contains naturally occurring marine omega-3 fatty acids in abundance and fish and other seafood also provide potentially beneficial protein, vitamins, and <a class="drug drug_general" data-topicid="9884" href="/z/d/drug information/9884.html" rel="external">selenium</a> [<a href="#rid70">70</a>]. The DHA and mercury content of fish vary independently, and several options are available that are both high in DHA and low in mercury. These include anchovies, Atlantic herring, Atlantic mackerel, mussels, oysters, farmed and wild salmon, sardines, snapper, and trout [<a href="#rid71">71,72</a>]. Of note, the most commonly consumed fish in the United States that are low in mercury (shrimp, farmed salmon, pollock, tilapia, cod, and catfish) vary considerably in their DHA content  (<a class="graphic graphic_table graphicRef79454" href="/z/d/graphic/79454.html" rel="external">table 1</a>), and weekly consumption of 12 oz of some of these fish may not provide adequate amounts of DHA [<a href="#rid73">73</a>].</p><p>In the United States, a US Food and Drug Administration and Environmental Protection Agency advisory recommends consumption of two to three weekly servings of a variety of types of seafood high in marine omega-3 fatty acids and low in mercury and other contaminants and completely avoiding consumption of fish high in mercury; an <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Ffood%2Fconsumers%2Fadvice-about-eating-fish&amp;token=3DQADYKgFxBBMUksGLB%2Bi2uBl7i0DSAGgwGhxlIeKIXGFCHPtIzQ4LgJUXWfIibcGA3bJmLer11zxi%2B6nj85bg%3D%3D&amp;TOPIC_ID=431" target="_blank">online table</a> to help consumers is available. The 2020-2025 Dietary Guidelines for Americans also include the same advice [<a href="#rid74">74</a>]. The US Environmental Protection Agency further recommends consulting local advisories about the safety of consuming fish caught in local lakes, rivers, and coastal areas. If no advisory is available, they suggest restricting intake of these fish to up to 6 oz (one average meal) per week and not consuming any other fish during that week.</p><p class="headingAnchor" id="H1171518462"><span class="h2">Marine omega-3 fatty acid supplements and fortified foods</span><span class="headingEndMark"> — </span>Most pregnant people do not consume fish several times per week, or they consume fish that will not achieve the recommended level of DHA intake [<a href="#rid64">64,75-78</a>]. For those who are not able or willing to consume fish of adequate DHA content, we suggest consumption of supplements or fortified foods to achieve DHA intake of at least 200 to 300 mg/day [<a href="#rid64">64-68</a>]. In an analysis of data from females of childbearing age in the US National Health and Nutrition Examination Survey (NHANES) cycles 2001 to 2002 through 2013 to 2014, the mean usual intake of seafood was 0.44±0.02 oz equivalent per day, and 100 percent of the population was below the current Dietary Guidelines for Americans (DGA) recommendation [<a href="#rid78">78</a>]. Mean usual intakes of EPA, DHA, and combined EPA and DHA from foods and dietary supplements combined were 26.8±1.4, 62.2±1.9, and 88.1±3.0 mg per day, respectively. Over 95 percent of the sample did not meet the daily intakes of 250 mg EPA and DHA. Similar results were observed for pregnant people.</p><p>A 2023 guideline recommended that pregnant individuals with low DHA intake and/or low DHA blood levels consume a supplement of about 600 to 1000 mg/day of DHA plus EPA or DHA alone beginning in the second trimester (not later than about 20 weeks of gestation) and continuing until about 37 weeks or until childbirth if before 37 weeks [<a href="#rid79">79</a>]. The guideline further noted that identification of individuals with inadequate omega-3 supply is achievable by a set of standardized questions on intake; DHA measurement from blood is another option to identify those with low status, but further standardization of laboratory methods and appropriate cutoff values are needed.</p><p>Supplements containing either <a class="drug drug_general" data-topicid="10255" href="/z/d/drug information/10255.html" rel="external">omega-3-acid ethyl esters</a> (fish oil) or DHA synthesized by algae are available in a variety of doses and include formulations marketed for pregnant people. Some prenatal vitamins and nonprescription marine omega-3 fatty acid supplements commonly available at major drug or health food stores contain DHA and EPA: the amount is on the label and varies among products [<a href="#rid80">80</a>]. These products also contain other marine omega-3 fatty acids, monounsaturated fats, saturated fats, and gelatin or <a class="drug drug_general" data-topicid="8959" href="/z/d/drug information/8959.html" rel="external">glycerin</a>; DHA and EPA typically account for ≤500 mg of a 1000 mg fish oil capsule [<a href="#rid81">81,82</a>]. Cod liver oil contains high concentrations of EPA and DHA but is less desirable than other fish oils because it also contains vitamin A, which is teratogenic at high doses. If a fish oil supplement causes a fishy taste, freezing it, switching to a different formulation, consumption with meals, or intake at a different time of day may minimize this symptom in some people.</p><p>A number of foods fortified with DHA are also available, including yogurt, milk, eggs, and cereals. However, many fortified foods contain the plant-based omega-3 fatty acids (ALA), rather than marine omega-3 fatty acids, and these cannot be considered a replacement for DHA and EPA because of low rates of conversion [<a href="#rid83">83</a>].</p><p>Very few trials have directly compared the effects of various doses or types of marine omega-3 fatty acid supplements, timing of initiation, or duration of use, or compared outcomes based on baseline characteristics of the study participants. A dose subgroup analysis in a 2018 meta-analysis of marine omega-3 fatty acid supplements during pregnancy did not identify a clear difference in birth outcomes based on dose (low [&lt;500 mg/day] versus mid [500 mg to 1 gram/day] versus high [&gt;1 gram/day] dose) or type of supplement (DHA versus mixed DHA/EPA) [<a href="#rid19">19</a>]. (See <a class="local">'Possible reduction in preterm birth, especially among those with low baseline omega-3 LCPUFA status'</a> above.)</p><p>The US Food and Drug Administration recommends that marine omega-3 fatty acid supplement labeling not recommend or suggest daily intake of more than 2 grams EPA and DHA [<a href="#rid84">84</a>], which is well above the amount recommended for pregnant people, females planning pregnancy, and breastfeeding people. Fish oil doses of 2.4 and 3.7 grams/day have been consumed in pregnancy without evidence of adverse effects [<a href="#rid23">23,85</a>]. In the general population, a total intake up to 3 grams/day of EPA and DHA is Generally Recognized As Safe (GRAS) [<a href="#rid86">86</a>] to "safeguard against the possible adverse effects of fatty acids on increased bleeding time."</p><p class="headingAnchor" id="H3570128464"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/131874.html" rel="external">"Society guideline links: Nutrition and supplements in pregnancy"</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>EPA and DHA</strong> – The two major categories of polyunsaturated fatty acids (PUFAs) are the omega-3 (also called n-3) and omega-6 (n-6) fatty acids. The three major dietary omega-3s are eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA). EPA and DHA are omega-3 long-chain PUFAs (LCPUFAs) present in fish, shellfish, and (in much lower amounts) some other animal foods. They are the major components of <a class="drug drug_general" data-topicid="10255" href="/z/d/drug information/10255.html" rel="external">omega-3-acid ethyl esters</a> (fish oil) supplements. Marine omega-3 fatty acids have a variety of biologic effects, including specific effects related to pregnancy. (See <a class="local">'Introduction'</a> above and <a class="local">'Background'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fish intake</strong> – Fish, including finfish and shellfish, is a healthful food that is low in saturated fat, high in protein and many vitamins, and is the primary dietary source of DHA and EPA. Individuals who may become pregnant, are currently pregnant, or are breastfeeding are generally advised to consume two or three weekly servings of a variety of the types of fish high in marine omega-3 fatty acids and low in mercury. This means not eating shark, swordfish, king mackerel, marlin, orange roughy, bigeye tuna, or tilefish because they can contain relatively high levels of mercury, which can cause neurotoxicity. Online tables are available for <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Ffood%2Fmetals-and-your-food%2Fmercury-levels-commercial-fish-and-shellfish-1990-2012&amp;token=IF2fUU3GLn2TBX5oCwJicHdnbvMmguMENAUN%2FQLHerJeqv%2FYFwWZEsDHDoTfTbHKOaJZLL%2BQezEA2eD6h1VUQcXLR47EB3cb%2FnZnJt%2BslKHzm1KeI19bmfpesttn4B94&amp;TOPIC_ID=431" target="_blank">mercury levels in fish</a> and <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Ffood%2Fconsumers%2Fadvice-about-eating-fish&amp;token=3DQADYKgFxBBMUksGLB%2Bi2uBl7i0DSAGgwGhxlIeKIXGFCHPtIzQ4LgJUXWfIibcGA3bJmLer11zxi%2B6nj85bg%3D%3D&amp;TOPIC_ID=431" target="_blank">to help consumers</a> make good choices. (See <a class="local">'Fish consumption'</a> above and <a class="local">'Methylmercury in fish'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>DHA fortified foods</strong> – A number of foods fortified with DHA are available, including yogurt, milk, and eggs. Supplements containing either fish oil or DHA synthesized by algae are also available. Prenatal vitamins may also contain DHA. (See <a class="local">'Marine omega-3 fatty acid supplements and fortified foods'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Recommendations for DHA intake during pregnancy</strong> – We suggest that pregnant people consume fish or, if this is not possible, consume a supplement or fortified food source of marine omega-3 fatty acids (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). We suggest an intake of at least 200 to 300 mg/day DHA. This level of fish intake/supplementation ideally should be started preconception or as early as possible in pregnancy. Oily fish contain more DHA than non-oily fish  (<a class="graphic graphic_table graphicRef79454" href="/z/d/graphic/79454.html" rel="external">table 1</a>). Pregnant individuals who have low omega-3 fatty acid status due to chronic low fish consumption or other low intake may consider taking a higher-dose supplement (600 to 1000 mg/day of DHA plus EPA or DHA alone). (See <a class="local">'Recommendations for people who are pregnant, planning pregnancy, and breastfeeding'</a> above.)</p><p></p><p class="bulletIndent1">This recommendation is based on evidence from some randomized trials showing a possible lower risk for preterm birth, a lower risk of persistent wheeze or asthma in offspring and no evidence of harm associated with marine omega-3 fatty acids as supplements or as dietary additions. It also acknowledges the observation that DHA is preferentially incorporated into the rapidly developing brain and retina during the last trimester and plays a role in various physiologic processes, although there is no clear evidence that marine omega-3 fatty acid supplements during pregnancy improve offspring neurodevelopment. (See <a class="local">'Possible beneficial effect on neurodevelopment'</a> above and <a class="local">'Possible reduction in preterm birth, especially among those with low baseline omega-3 LCPUFA status'</a> above and <a class="local">'Possible reduction in allergy and atopic disease'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992; 120:S129.</a></li><li class="breakAll">Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Micronutrients). The National Academies Press; Washington, DC 2002/2005.</li><li><a class="nounderline abstract_t">McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005; 82:281.</a></li><li><a class="nounderline abstract_t">Lewin GA, Schachter HM, Yuen D, et al. Effects of omega-3 fatty acids on child and maternal health. Evid Rep Technol Assess (Summ) 2005; :1.</a></li><li><a class="nounderline abstract_t">Larqué E, Krauss-Etschmann S, Campoy C, et al. Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am J Clin Nutr 2006; 84:853.</a></li><li><a class="nounderline abstract_t">Xu LZ, Sánchez R, Sali A, Heintz N. Ligand specificity of brain lipid-binding protein. J Biol Chem 1996; 271:24711.</a></li><li><a class="nounderline abstract_t">Clandinin MT, Chappell JE, Heim T, et al. Fatty acid utilization in perinatal de novo synthesis of tissues. Early Hum Dev 1981; 5:355.</a></li><li><a class="nounderline abstract_t">Oken E, Wright RO, Kleinman KP, et al. Maternal fish consumption, hair mercury, and infant cognition in a U.S. Cohort. Environ Health Perspect 2005; 113:1376.</a></li><li><a class="nounderline abstract_t">Oken E, Radesky JS, Wright RO, et al. Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am J Epidemiol 2008; 167:1171.</a></li><li><a class="nounderline abstract_t">Oken E, Østerdal ML, Gillman MW, et al. Associations of maternal fish intake during pregnancy and breastfeeding duration with attainment of developmental milestones in early childhood: a study from the Danish National Birth Cohort. Am J Clin Nutr 2008; 88:789.</a></li><li><a class="nounderline abstract_t">Hibbeln JR, Davis JM, Steer C, et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 2007; 369:578.</a></li><li><a class="nounderline abstract_t">Gale CR, Robinson SM, Godfrey KM, et al. Oily fish intake during pregnancy--association with lower hyperactivity but not with higher full-scale IQ in offspring. J Child Psychol Psychiatry 2008; 49:1061.</a></li><li><a class="nounderline abstract_t">Lederman SA, Jones RL, Caldwell KL, et al. Relation between cord blood mercury levels and early child development in a World Trade Center cohort. Environ Health Perspect 2008; 116:1085.</a></li><li><a class="nounderline abstract_t">Boucher O, Burden MJ, Muckle G, et al. Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age. Am J Clin Nutr 2011; 93:1025.</a></li><li><a class="nounderline abstract_t">Sagiv SK, Thurston SW, Bellinger DC, et al. Prenatal exposure to mercury and fish consumption during pregnancy and attention-deficit/hyperactivity disorder-related behavior in children. Arch Pediatr Adolesc Med 2012; 166:1123.</a></li><li><a class="nounderline abstract_t">Julvez J, Méndez M, Fernandez-Barres S, et al. Maternal Consumption of Seafood in Pregnancy and Child Neuropsychological Development: A Longitudinal Study Based on a Population With High Consumption Levels. Am J Epidemiol 2016; 183:169.</a></li><li><a class="nounderline abstract_t">Budtz-Jørgensen E, Grandjean P, Weihe P. Separation of risks and benefits of seafood intake. Environ Health Perspect 2007; 115:323.</a></li><li><a class="nounderline abstract_t">Davidson PW, Cory-Slechta DA, Thurston SW, et al. Fish consumption and prenatal methylmercury exposure: cognitive and behavioral outcomes in the main cohort at 17 years from the Seychelles child development study. Neurotoxicology 2011; 32:711.</a></li><li><a class="nounderline abstract_t">Middleton P, Gomersall JC, Gould JF, et al. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev 2018; 11:CD003402.</a></li><li class="breakAll">Benefit and risk assessment of fish in the Norwegian diet. Norwegian Scientific Committee for Food and Environment (VKM). 2022. Available at: https://vkm.no/english/riskassessments/allpublications/benefitandriskassessmentoffishinthenorwegiandiet.4.7b65040716afa427d7ec5d3a.html (Accessed on December 12, 2023).</li><li><a class="nounderline abstract_t">Cave C, Hein N, Smith LM, et al. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake by Ethnicity, Income, and Education Level in the United States: NHANES 2003-2014. Nutrients 2020; 12.</a></li><li><a class="nounderline abstract_t">Vahdaninia M, Mackenzie H, Dean T, Helps S. ω-3 LCPUFA supplementation during pregnancy and risk of allergic outcomes or sensitization in offspring: A systematic review and meta-analysis. Ann Allergy Asthma Immunol 2019; 122:302.</a></li><li><a class="nounderline abstract_t">Bisgaard H, Stokholm J, Chawes BL, et al. Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring. N Engl J Med 2016; 375:2530.</a></li><li><a class="nounderline abstract_t">Malmir H, Larijani B, Esmaillzadeh A. Fish consumption during pregnancy and risk of allergic diseases in the offspring: A systematic review and meta-analysis. Crit Rev Food Sci Nutr 2022; 62:7449.</a></li><li><a class="nounderline abstract_t">Serra R, Peñailillo R, Monteiro LJ, et al. Supplementation of Omega 3 during Pregnancy and the Risk of Preterm Birth: A Systematic Review and Meta-Analysis. Nutrients 2021; 13.</a></li><li><a class="nounderline abstract_t">Best KP, Gibson RA, Makrides M. ISSFAL statement number 7 - Omega-3 fatty acids during pregnancy to reduce preterm birth. Prostaglandins Leukot Essent Fatty Acids 2022; 186:102495.</a></li><li><a class="nounderline abstract_t">Zhao R, Gao Q, Wang S, et al. The effect of maternal seafood consumption on perinatal outcomes: a systematic review and dose-response meta-analysis. Crit Rev Food Sci Nutr 2021; 61:3504.</a></li><li><a class="nounderline abstract_t">Saccone G, Saccone I, Berghella V. Omega-3 long-chain polyunsaturated fatty acids and fish oil supplementation during pregnancy: which evidence? J Matern Fetal Neonatal Med 2016; 29:2389.</a></li><li><a class="nounderline abstract_t">Olsen SF, Secher NJ, Tabor A, et al. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG 2000; 107:382.</a></li><li><a class="nounderline abstract_t">Bulstra-Ramakers MT, Huisjes HJ, Visser GH. The effects of 3g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. Br J Obstet Gynaecol 1995; 102:123.</a></li><li><a class="nounderline abstract_t">Onwude JL, Lilford RJ, Hjartardottir H, et al. A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol 1995; 102:95.</a></li><li><a class="nounderline abstract_t">Lando AM, Fein SB, Choinière CJ. Awareness of methylmercury in fish and fish consumption among pregnant and postpartum women and women of childbearing age in the United States. Environ Res 2012; 116:85.</a></li><li><a class="nounderline abstract_t">Castoldi AF, Coccini T, Ceccatelli S, Manzo L. Neurotoxicity and molecular effects of methylmercury. Brain Res Bull 2001; 55:197.</a></li><li><a class="nounderline abstract_t">Harada M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 1995; 25:1.</a></li><li><a class="nounderline abstract_t">Amin-Zaki L, Elhassani S, Majeed MA, et al. Intra-uterine methylmercury poisoning in Iraq. Pediatrics 1974; 54:587.</a></li><li><a class="nounderline abstract_t">Crump KS, Kjellström T, Shipp AM, et al. Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort. Risk Anal 1998; 18:701.</a></li><li><a class="nounderline abstract_t">Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997; 19:417.</a></li><li><a class="nounderline abstract_t">Debes F, Budtz-Jørgensen E, Weihe P, et al. Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years. Neurotoxicol Teratol 2006; 28:536.</a></li><li><a class="nounderline abstract_t">Myers GJ, Davidson PW, Cox C, et al. Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 2003; 361:1686.</a></li><li><a class="nounderline abstract_t">van Wijngaarden E, Thurston SW, Myers GJ, et al. Prenatal methyl mercury exposure in relation to neurodevelopment and behavior at 19 years of age in the Seychelles Child Development Study. Neurotoxicol Teratol 2013; 39:19.</a></li><li><a class="nounderline abstract_t">Strain JJ, Love TM, Yeates AJ, et al. Associations of prenatal methylmercury exposure and maternal polyunsaturated fatty acid status with neurodevelopmental outcomes at 7 years of age: results from the Seychelles Child Development Study Nutrition Cohort 2. Am J Clin Nutr 2021; 113:304.</a></li><li><a class="nounderline abstract_t">Hu Y, Chen L, Wang C, et al. Prenatal low-level mercury exposure and infant neurodevelopment at 12 months in rural northern China. Environ Sci Pollut Res Int 2016; 23:12050.</a></li><li><a class="nounderline abstract_t">Golding J, Gregory S, Iles-Caven Y, et al. Associations between prenatal mercury exposure and early child development in the ALSPAC study. Neurotoxicology 2016; 53:215.</a></li><li><a class="nounderline abstract_t">Xu Y, Khoury JC, Sucharew H, et al. Low-level gestational exposure to mercury and maternal fish consumption: Associations with neurobehavior in early infancy. Neurotoxicol Teratol 2016; 54:61.</a></li><li><a class="nounderline abstract_t">Oken E, Rifas-Shiman SL, Amarasiriwardena C, et al. Maternal prenatal fish consumption and cognition in mid childhood: Mercury, fatty acids, and selenium. Neurotoxicol Teratol 2016; 57:71.</a></li><li><a class="nounderline abstract_t">Golding J, Gregory S, Emond A, et al. Prenatal mercury exposure and offspring behaviour in childhood and adolescence. Neurotoxicology 2016; 57:87.</a></li><li><a class="nounderline abstract_t">Rice DC, Schoeny R, Mahaffey K. Methods and rationale for derivation of a reference dose for methylmercury by the U.S. EPA. Risk Anal 2003; 23:107.</a></li><li class="breakAll">Toxicological profile for mercury. US Agency for Toxic Substances and Disease Registry; US Department of Health and Human Services, Atlanta, GA 1999.</li><li class="breakAll">FAO/WHO Joint Expert Committee on Food Additives. Evaluation of certain food additives and contaminants (61st report of the Joint FAO/WHO Expert Committee on Food Additives). No. 22, WHO Technical Report Series; 2004.</li><li class="breakAll">Health Canada. Human health risk assessment of mercury in fish and health benefits of fish consumption. Health Canada; Ottawa, 2007.</li><li><a class="nounderline abstract_t">Karimi R, Fitzgerald TP, Fisher NS. A quantitative synthesis of mercury in commercial seafood and implications for exposure in the United States. Environ Health Perspect 2012; 120:1512.</a></li><li><a class="nounderline abstract_t">Felton DJ, Kales SN, Goldman RH. An update and review of unconventional metals testing and treatment. Toxics 2014; 2:403.</a></li><li><a class="nounderline abstract_t">Hightower JM, Moore D. Mercury levels in high-end consumers of fish. Environ Health Perspect 2003; 111:604.</a></li><li><a class="nounderline abstract_t">Cusack LK, Smit E, Kile ML, Harding AK. Regional and temporal trends in blood mercury concentrations and fish consumption in women of child bearing Age in the united states using NHANES data from 1999-2010. Environ Health 2017; 16:10.</a></li><li><a class="nounderline abstract_t">Foran SE, Flood JG, Lewandrowski KB. Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med 2003; 127:1603.</a></li><li><a class="nounderline abstract_t">Melanson SF, Lewandrowski EL, Flood JG, Lewandrowski KB. Measurement of organochlorines in commercial over-the-counter fish oil preparations: implications for dietary and therapeutic recommendations for omega-3 fatty acids and a review of the literature. Arch Pathol Lab Med 2005; 129:74.</a></li><li><a class="nounderline abstract_t">Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006; 84:5.</a></li><li class="breakAll">https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/#en5 (Accessed on January 17, 2019).</li><li><a class="nounderline abstract_t">Kleiner AC, Cladis DP, Santerre CR. A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements in the United States. J Sci Food Agric 2015; 95:1260.</a></li><li><a class="nounderline abstract_t">Yi T, Li SM, Fan JY, et al. Comparative analysis of EPA and DHA in fish oil nutritional capsules by GC-MS. Lipids Health Dis 2014; 13:190.</a></li><li><a class="nounderline abstract_t">Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003; 111:e39.</a></li><li><a class="nounderline abstract_t">Helland IB, Saugstad OD, Saarem K, et al. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Matern Fetal Neonatal Med 2006; 19:397.</a></li><li><a class="nounderline abstract_t">Miles EA, Noakes PS, Kremmyda LS, et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n-3 fatty acid intake, and marine n-3 fatty acid status in maternal and umbilical cord blood. Am J Clin Nutr 2011; 94:1986S.</a></li><li><a class="nounderline abstract_t">Koletzko B, Cetin I, Brenna JT, et al. Dietary fat intakes for pregnant and lactating women. Br J Nutr 2007; 98:873.</a></li><li><a class="nounderline abstract_t">Simopoulos AP, Leaf A, Salem N Jr. Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2000; 63:119.</a></li><li><a class="nounderline abstract_t">Koletzko B, Lien E, Agostoni C, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 2008; 36:5.</a></li><li class="breakAll">March of Dimes. Omega-3 fatty acids during pregnancy. March of Dimes, 2009. http://www.marchofdimes.com/pnhec/159_55030.asp (Accessed on June 17, 2009).</li><li><a class="nounderline abstract_t">Koletzko B, Bauer CP, Bung P, et al. German national consensus recommendations on nutrition and lifestyle in pregnancy by the 'Healthy Start - Young Family Network'. Ann Nutr Metab 2013; 63:311.</a></li><li class="breakAll">Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Institute of Medicine. 2006. Washington, DC: The National Academies Press. https://doi.org/10.17226/11537.</li><li class="breakAll">US Department of Agriculture. USDA National Nutrient Database for Standard Reference: Release 18 (2005). US Department of Agriculture, Agricultural Research Service, 2006.</li><li><a class="nounderline abstract_t">Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006; 296:1885.</a></li><li><a class="nounderline abstract_t">Domingo JL, Bocio A, Falcó G, Llobet JM. Benefits and risks of fish consumption Part I. A quantitative analysis of the intake of omega-3 fatty acids and chemical contaminants. Toxicology 2007; 230:219.</a></li><li class="breakAll">Fish: What pregnant women and parents should know. Draft updated advice by US Food and Drug Administration and Environmental Protection Agency. http://www.fda.gov/Food/FoodborneIllnessContaminants/Metals/ucm393070.htm (Accessed on June 13, 2014).</li><li class="breakAll">Dietary Guidelines for Americans, 2020-2025. Available at: https://www.dietaryguidelines.gov/ (Accessed on December 21, 2021).</li><li><a class="nounderline abstract_t">Oken E, Kleinman KP, Berland WE, et al. Decline in fish consumption among pregnant women after a national mercury advisory. Obstet Gynecol 2003; 102:346.</a></li><li><a class="nounderline abstract_t">Meyer BJ. Australians are not Meeting the Recommended Intakes for Omega-3 Long Chain Polyunsaturated Fatty Acids: Results of an Analysis from the 2011-2012 National Nutrition and Physical Activity Survey. Nutrients 2016; 8:111.</a></li><li><a class="nounderline abstract_t">Eickstaedt M, Beck KL, Conlon CA. New Zealand women have suboptimal intakes of long chain omega-3 polyunsaturated fatty acids during pregnancy-a cross sectional study. N Z Med J 2017; 130:37.</a></li><li><a class="nounderline abstract_t">Zhang Z, Fulgoni VL, Kris-Etherton PM, Mitmesser SH. Dietary Intakes of EPA and DHA Omega-3 Fatty Acids among US Childbearing-Age and Pregnant Women: An Analysis of NHANES 2001-2014. Nutrients 2018; 10.</a></li><li><a class="nounderline abstract_t">Cetin I, Carlson SE, Burden C, et al. Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth. Am J Obstet Gynecol MFM 2023; 6:101251.</a></li><li class="breakAll">Santerre C, November 9, 2007, personal communication.</li><li class="breakAll">Omacor: Consumer drug information sheet - Approval label. US Food and Drug Administration, Center for Drug Evaluation and Research. www.fda.gov/cder/foi/label/2004/21654lbl.pdf (Accessed on December 21, 2007).</li><li><a class="nounderline abstract_t">Chee KM, Gong JX, Rees DM, et al. Fatty acid content of marine oil capsules. Lipids 1990; 25:523.</a></li><li><a class="nounderline abstract_t">Mozaffarian D. Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence. Altern Ther Health Med 2005; 11:24.</a></li><li class="breakAll">Letter responding to a request to reconsider the qualified claim for a dietary supplement health claim for omega-3 fatty acids and coronary heart disease. Office of Nutritional Products, Labeling, and Dietary Supplements, Center for Food Safety and Applied Nutrition, US Food and Drug Administration, 2002. www.cfsan.fda.gov/~dms/ds-ltr28.html (Accessed on December 21, 2007).</li><li><a class="nounderline abstract_t">Zhang GQ, Liu B, Li J, et al. Fish intake during pregnancy or infancy and allergic outcomes in children: A systematic review and meta-analysis. Pediatr Allergy Immunol 2017; 28:152.</a></li><li class="breakAll">Substances affirmed as Generally Recognized As Safe: Menhaden oil. Department of Health and Human Services, US Food and Drug Administration. www.fda.gov/OHRMS/DOCKETS/98fr/05-5641.htm (Accessed on June 30, 2008).</li></ol></div><div id="topicVersionRevision">Topic 431 Version 54.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1532827" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Tissue levels of polyunsaturated fatty acids during early human development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1532827" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Tissue levels of polyunsaturated fatty acids during early human development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16087970" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16194124" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Effects of omega-3 fatty acids on child and maternal health.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17023713" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8798739" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Ligand specificity of brain lipid-binding protein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7285840" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Fatty acid utilization in perinatal de novo synthesis of tissues.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16203250" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Maternal fish consumption, hair mercury, and infant cognition in a U.S. Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18353804" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18779297" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Associations of maternal fish intake during pregnancy and breastfeeding duration with attainment of developmental milestones in early childhood: a study from the Danish National Birth Cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17307104" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18422546" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Oily fish intake during pregnancy--association with lower hyperactivity but not with higher full-scale IQ in offspring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18709170" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Relation between cord blood mercury levels and early child development in a World Trade Center cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21389181" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23044994" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Prenatal exposure to mercury and fish consumption during pregnancy and attention-deficit/hyperactivity disorder-related behavior in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26740026" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Maternal Consumption of Seafood in Pregnancy and Child Neuropsychological Development: A Longitudinal Study Based on a Population With High Consumption Levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17431478" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Separation of risks and benefits of seafood intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21889535" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Fish consumption and prenatal methylmercury exposure: cognitive and behavioral outcomes in the main cohort at 17 years from the Seychelles child development study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30480773" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Omega-3 fatty acid addition during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30480773" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Omega-3 fatty acid addition during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32660046" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake by Ethnicity, Income, and Education Level in the United States: NHANES 2003-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30552987" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : ω-3 LCPUFA supplementation during pregnancy and risk of allergic outcomes or sensitization in offspring: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28029926" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34128430" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Fish consumption during pregnancy and risk of allergic diseases in the offspring: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34069867" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Supplementation of Omega 3 during Pregnancy and the Risk of Preterm Birth: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36228573" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : ISSFAL statement number 7 - Omega-3 fatty acids during pregnancy to reduce preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32748625" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The effect of maternal seafood consumption on perinatal outcomes: a systematic review and dose-response meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26382010" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Omega-3 long-chain polyunsaturated fatty acids and fish oil supplementation during pregnancy: which evidence?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10740336" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7756203" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The effects of 3g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7756226" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : A randomised double blind placebo controlled trial of fish oil in high risk pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22534145" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Awareness of methylmercury in fish and fish consumption among pregnant and postpartum women and women of childbearing age in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11470315" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Neurotoxicity and molecular effects of methylmercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7734058" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Minamata disease: methylmercury poisoning in Japan caused by environmental pollution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4480317" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Intra-uterine methylmercury poisoning in Iraq.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9972579" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9392777" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17067778" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12767734" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23770126" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Prenatal methyl mercury exposure in relation to neurodevelopment and behavior at 19 years of age in the Seychelles Child Development Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33330939" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Associations of prenatal methylmercury exposure and maternal polyunsaturated fatty acid status with neurodevelopmental outcomes at 7 years of age: results from the Seychelles Child Development Study Nutrition Cohort 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26965274" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Prenatal low-level mercury exposure and infant neurodevelopment at 12 months in rural northern China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26880023" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Associations between prenatal mercury exposure and early child development in the ALSPAC study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26876455" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Low-level gestational exposure to mercury and maternal fish consumption: Associations with neurobehavior in early infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27381635" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Maternal prenatal fish consumption and cognition in mid childhood: Mercury, fatty acids, and selenium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27633321" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Prenatal mercury exposure and offspring behaviour in childhood and adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12635727" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Methods and rationale for derivation of a reference dose for methylmercury by the U.S. EPA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12635727" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Methods and rationale for derivation of a reference dose for methylmercury by the U.S. EPA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12635727" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Methods and rationale for derivation of a reference dose for methylmercury by the U.S. EPA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12635727" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Methods and rationale for derivation of a reference dose for methylmercury by the U.S. EPA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22732656" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : A quantitative synthesis of mercury in commercial seafood and implications for exposure in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : An update and review of unconventional metals testing and treatment</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12676623" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Mercury levels in high-end consumers of fish.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28212649" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Regional and temporal trends in blood mercury concentrations and fish consumption in women of child bearing Age in the united states using NHANES data from 1999-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14632570" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15628911" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Measurement of organochlorines in commercial over-the-counter fish oil preparations: implications for dietary and therapeutic recommendations for omega-3 fatty acids and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16825676" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16825676" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25044306" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25496531" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Comparative analysis of EPA and DHA in fish oil nutritional capsules by GC-MS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12509593" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16923694" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21849598" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n-3 fatty acid intake, and marine n-3 fatty acid status in maternal and umbilical cord blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17688705" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Dietary fat intakes for pregnant and lactating women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10991764" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18184094" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18184094" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24514069" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : German national consensus recommendations on nutrition and lifestyle in pregnancy by the 'Healthy Start - Young Family Network'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24514069" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : German national consensus recommendations on nutrition and lifestyle in pregnancy by the 'Healthy Start - Young Family Network'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24514069" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : German national consensus recommendations on nutrition and lifestyle in pregnancy by the 'Healthy Start - Young Family Network'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17047219" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Fish intake, contaminants, and human health: evaluating the risks and the benefits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17161894" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Benefits and risks of fish consumption Part I. A quantitative analysis of the intake of omega-3 fatty acids and chemical contaminants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17161894" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Benefits and risks of fish consumption Part I. A quantitative analysis of the intake of omega-3 fatty acids and chemical contaminants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17161894" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Benefits and risks of fish consumption Part I. A quantitative analysis of the intake of omega-3 fatty acids and chemical contaminants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12907111" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Decline in fish consumption among pregnant women after a national mercury advisory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26927162" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Australians are not Meeting the Recommended Intakes for Omega-3 Long Chain Polyunsaturated Fatty Acids: Results of an Analysis from the 2011-2012 National Nutrition and Physical Activity Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28934766" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : New Zealand women have suboptimal intakes of long chain omega-3 polyunsaturated fatty acids during pregnancy-a cross sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29597261" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Dietary Intakes of EPA and DHA Omega-3 Fatty Acids among US Childbearing-Age and Pregnant Women: An Analysis of NHANES 2001-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38070679" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38070679" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38070679" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Omega-3 fatty acid supply in pregnancy for risk reduction of preterm and early preterm birth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2250588" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Fatty acid content of marine oil capsules.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15945135" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15945135" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27590571" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Fish intake during pregnancy or infancy and allergic outcomes in children: A systematic review and meta-analysis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
